|
Atomistry » Fluorine » PDB 5ug8-5uv1 » 5ugc | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Atomistry » Fluorine » PDB 5ug8-5uv1 » 5ugc » |
Fluorine in PDB 5ugc: Crystal Structure of the Egfr Kinase Domain (L858R, T790M, V948R) in Complex with A Covalent Inhibitor N-[(3R,4R)-4-Fluoro-1-{6-[(3- Methoxy-1-Methyl-1H-Pyrazol-4-Yl)Amino]-9-Methyl-9H-Purin-2- Yl}Pyrrolidin-3-Yl]PropanamideEnzymatic activity of Crystal Structure of the Egfr Kinase Domain (L858R, T790M, V948R) in Complex with A Covalent Inhibitor N-[(3R,4R)-4-Fluoro-1-{6-[(3- Methoxy-1-Methyl-1H-Pyrazol-4-Yl)Amino]-9-Methyl-9H-Purin-2- Yl}Pyrrolidin-3-Yl]Propanamide
All present enzymatic activity of Crystal Structure of the Egfr Kinase Domain (L858R, T790M, V948R) in Complex with A Covalent Inhibitor N-[(3R,4R)-4-Fluoro-1-{6-[(3- Methoxy-1-Methyl-1H-Pyrazol-4-Yl)Amino]-9-Methyl-9H-Purin-2- Yl}Pyrrolidin-3-Yl]Propanamide:
2.7.10.1; Protein crystallography data
The structure of Crystal Structure of the Egfr Kinase Domain (L858R, T790M, V948R) in Complex with A Covalent Inhibitor N-[(3R,4R)-4-Fluoro-1-{6-[(3- Methoxy-1-Methyl-1H-Pyrazol-4-Yl)Amino]-9-Methyl-9H-Purin-2- Yl}Pyrrolidin-3-Yl]Propanamide, PDB code: 5ugc
was solved by
K.S.Gajiwala,
R.A.Ferre,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Fluorine Binding Sites:
The binding sites of Fluorine atom in the Crystal Structure of the Egfr Kinase Domain (L858R, T790M, V948R) in Complex with A Covalent Inhibitor N-[(3R,4R)-4-Fluoro-1-{6-[(3- Methoxy-1-Methyl-1H-Pyrazol-4-Yl)Amino]-9-Methyl-9H-Purin-2- Yl}Pyrrolidin-3-Yl]Propanamide
(pdb code 5ugc). This binding sites where shown within
5.0 Angstroms radius around Fluorine atom.
In total only one binding site of Fluorine was determined in the Crystal Structure of the Egfr Kinase Domain (L858R, T790M, V948R) in Complex with A Covalent Inhibitor N-[(3R,4R)-4-Fluoro-1-{6-[(3- Methoxy-1-Methyl-1H-Pyrazol-4-Yl)Amino]-9-Methyl-9H-Purin-2- Yl}Pyrrolidin-3-Yl]Propanamide, PDB code: 5ugc: Fluorine binding site 1 out of 1 in 5ugcGo back to Fluorine Binding Sites List in 5ugc
Fluorine binding site 1 out
of 1 in the Crystal Structure of the Egfr Kinase Domain (L858R, T790M, V948R) in Complex with A Covalent Inhibitor N-[(3R,4R)-4-Fluoro-1-{6-[(3- Methoxy-1-Methyl-1H-Pyrazol-4-Yl)Amino]-9-Methyl-9H-Purin-2- Yl}Pyrrolidin-3-Yl]Propanamide
Mono view Stereo pair view
Reference:
S.Planken,
D.C.Behenna,
S.K.Nair,
T.O.Johnson,
A.Nagata,
C.Almaden,
S.Bailey,
T.E.Ballard,
L.Bernier,
H.Cheng,
S.Cho-Schultz,
D.Dalvie,
J.G.Deal,
D.M.Dinh,
M.P.Edwards,
R.A.Ferre,
K.S.Gajiwala,
M.Hemkens,
R.S.Kania,
J.C.Kath,
J.Matthews,
B.W.Murray,
S.Niessen,
S.T.Orr,
M.Pairish,
N.W.Sach,
H.Shen,
M.Shi,
J.Solowiej,
K.Tran,
E.Tseng,
P.Vicini,
Y.Wang,
S.L.Weinrich,
R.Zhou,
M.Zientek,
L.Liu,
Y.Luo,
S.Xin,
C.Zhang,
J.Lafontaine.
Discovery of N-((3R,4R)-4-Fluoro-1-(6-((3-Methoxy-1-Methyl-1H-Pyrazol-4-Y L)Amino)-9-Methyl-9H-Purin-2-Yl)Pyrrolidine-3-Yl)Acrylamide (Pf-06747775) Through Structure-Based Drug Design: A High Affinity Irreversible Inhibitor Targeting Oncogenic Egfr Mutants with Selectivity Over Wild-Type Egfr. J. Med. Chem. V. 60 3002 2017.
Page generated: Thu Aug 1 15:40:11 2024
ISSN: ISSN 1520-4804 PubMed: 28287730 DOI: 10.1021/ACS.JMEDCHEM.6B01894 |
Last articlesZn in 9JYWZn in 9IR4 Zn in 9IR3 Zn in 9GMX Zn in 9GMW Zn in 9JEJ Zn in 9ERF Zn in 9ERE Zn in 9EGV Zn in 9EGW |
© Copyright 2008-2020 by atomistry.com | ||
Home | Site Map | Copyright | Contact us | Privacy |